Prosecution Insights
Last updated: October 04, 2026

NOF Corporation

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

13 pending office actions • 9 art units • 13 examiners • 0 of 13 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days

Analysis

NOF Corporation currently has 13 pending office actions within the Chemistry & Materials technology area. These 13 actions are assigned to 13 distinct examiners, meaning every pending matter is being reviewed by a different individual. These applications are spread across 9 distinct art units, showing a level of technical dispersion within the patent office.

MELLOTT, JAMES M is identified as the busiest examiner, though they are only handling 1 pending office action. Because there are 13 distinct examiners for 13 pending actions, the workload is distributed with no examiner overlap. The 9 distinct art units involved suggest that the company's Chemistry & Materials portfolio covers several different specialized chemical or material classifications. Practitioners must manage 13 different examiners across 9 art units, which may lead to varied prosecution experiences despite the shared technology area.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

13
Total Pending OAs
10
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
3
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 30 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (23%)
10
Medium (77%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (46%)
§102 only1 (8%)
Double-patenting + other3 (23%)
Multi-statute (no §101)3 (23%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
62% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
8% of docket
0
Mechanical / Eng
0% of docket
4
Business / Other
31% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

130 h
Manual time on pending OAs
26 h
Time saved (low, 20%)
46 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MELLOTT, JAMES M 1 51.1% +44.2%
PALLAY, MICHAEL B 1 55.8% +34.0%
HERNANDEZ, JACKSON J 1 51.4% +45.0%
OLADAPO, TAIWO 1 52.9% +11.8%
BOYLE, ROBERT C 1 69.7% -2.7%
ATKINSON, JOSHUA ALEXANDER 1 52.4% +26.7%
LING, DORIS 1 25.0% +27.3%
WASHVILLE, JEFFREY D 1 80.0% -4.5%
FROST, ANTHONY J 1 52.7% +20.1%
JONES, CHRISTINE MICHELLE 1 0.0% +0.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18573698 CONTACT LENS AND PRODUCTION METHOD FOR SAID LENS WASHVILLE, JEFFREY D —

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18458354 REACTION COMPOSITION FOR NUCLEIC ACID AMPLIFICATION AND NUCLEIC ACID AMPLIFICATION METHOD USING SAME JONES, CHRISTINE MICHELLE 27d
18869004 OIL FOR COSMETIC AND COSMETIC CONTAINING SAME PALLAY, MICHAEL B —
18695576 POLYMER FOR WATER-REPELLENT, WATER-REPELLENT COMPOSITION, AND WATER REPELLENT-TREATED PRODUCT BOYLE, ROBERT C —
18683446 ANTIFOGGING AGENT COMPOSITION, AND ANTIFOGGING ARTICLE LING, DORIS —
18263416 SENSITIZER FOR NUCLEIC ACID AMPLIFICATION, COMPOSITION FOR NUCLEIC ACID AMPLIFICATION, AND TEST KIT KARST, DAVID THOMAS —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18702370 LUBRICANT COMPOSITION OLADAPO, TAIWO 29d
19132073 FILM-FORMING AUXILIARY AGENT FOR CHEMICAL VAPOR DEPOSITION, COATING SOLUTION FOR CHEMICAL VAPOR DEPOSITION, METAL OXIDE FILM, AND FILM-FORMING METHOD FOR METAL OXIDE FILM MELLOTT, JAMES M —
18869004 OIL FOR COSMETIC AND COSMETIC CONTAINING SAME PALLAY, MICHAEL B —
18913388 KETAL-TYPE RELEASABLE POLYOXYETHYLENE DERIVATIVE, PRODUCTION METHOD THEREOF AND KETAL-TYPE RELEASABLE POLYOXYETHYLENE CONJUGATE HERNANDEZ, JACKSON J —
18683917 OIL FOR COSMETICS, AND COSMETIC CONTAINING SAME ATKINSON, JOSHUA ALEXANDER —
18683446 ANTIFOGGING AGENT COMPOSITION, AND ANTIFOGGING ARTICLE LING, DORIS —
18281874 CURABLE RESIN COMPOSITION FOR USE IN SEALING MATERIAL FOR FILM LIQUID CRYSTAL PANEL, AND FILM LIQUID CRYSTAL PANEL HAVING END SEALED BY SAID CURABLE RESIN COMPOSITION FROST, ANTHONY J —

Top Art Units

Art UnitApps
1759 1
1771 1
1612 1
2872 1
1782 1
1682 1
1767 1
1762 1
1622 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19132073 FILM-FORMING AUXILIARY AGENT FOR CHEMICAL VAPOR DEPOSITION, COATING SOLUTION FOR CHEMICAL VAPOR DEPOSITION, METAL OXIDE FILM, AND FILM-FORMING METHOD FOR METAL OXIDE FILM MELLOTT, JAMES M 1759 §102 Non-Final OA — Pending May 22, 2025
18869004 OIL FOR COSMETIC AND COSMETIC CONTAINING SAME PALLAY, MICHAEL B — §102§103 Non-Final OA — Pending Nov 25, 2024
18913388 KETAL-TYPE RELEASABLE POLYOXYETHYLENE DERIVATIVE, PRODUCTION METHOD THEREOF AND KETAL-TYPE RELEASABLE POLYOXYETHYLENE CONJUGATE HERNANDEZ, JACKSON J — §103DP Non-Final OA — Pending Oct 11, 2024
18702370 LUBRICANT COMPOSITION OLADAPO, TAIWO 1771 §103 Non-Final OA 29d Pending Apr 18, 2024
18695576 POLYMER FOR WATER-REPELLENT, WATER-REPELLENT COMPOSITION, AND WATER REPELLENT-TREATED PRODUCT BOYLE, ROBERT C — §102§103 Non-Final OA — Pending Mar 26, 2024
18683917 OIL FOR COSMETICS, AND COSMETIC CONTAINING SAME ATKINSON, JOSHUA ALEXANDER 1612 §103DP Final Rejection — Pending Feb 15, 2024
18683446 ANTIFOGGING AGENT COMPOSITION, AND ANTIFOGGING ARTICLE LING, DORIS — §103 Non-Final OA — Pending Feb 13, 2024
18573698 CONTACT LENS AND PRODUCTION METHOD FOR SAID LENS WASHVILLE, JEFFREY D 2872 §103 Non-Final OA — Pending Dec 22, 2023
18281874 CURABLE RESIN COMPOSITION FOR USE IN SEALING MATERIAL FOR FILM LIQUID CRYSTAL PANEL, AND FILM LIQUID CRYSTAL PANEL HAVING END SEALED BY SAID CURABLE RESIN COMPOSITION FROST, ANTHONY J 1782 §103 Final Rejection — Pending Sep 13, 2023
18458354 REACTION COMPOSITION FOR NUCLEIC ACID AMPLIFICATION AND NUCLEIC ACID AMPLIFICATION METHOD USING SAME JONES, CHRISTINE MICHELLE 1682 §102§103§112DP Non-Final OA 27d Pending Aug 30, 2023
18263416 SENSITIZER FOR NUCLEIC ACID AMPLIFICATION, COMPOSITION FOR NUCLEIC ACID AMPLIFICATION, AND TEST KIT KARST, DAVID THOMAS 1767 §102§103 Final Rejection — Pending Jul 28, 2023
18267163 RUBBER COMPOSITION FOR HOT AIR CROSS-LINKING, CROSS-LINKED RUBBER, AND PRODUCTION METHOD OF CROSS-LINKED RUBBER AMATO, ELIZABETH KATHRYN 1762 §103 Non-Final OA 20d Pending Jun 14, 2023
18176420 ALKYLENE OXIDE DERIVATIVES, WETTING AGENT, SOLUBILIZING AGENT, AND SOLUBILIZING COMPOSITION WARD, PAUL V 1622 §103 Non-Final OA — Pending Feb 28, 2023

Managing NOF Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month